RGEN - Past Earnings And Revenue Growth Have Pushed Repligen Higher Ahead Of Q4 Earnings
- Medical supplier Repligen is set to report fourth quarter earnings on Feb. 24.
- Analysts expect EPS to grow by 55% and revenue to grow by 35.1%.
- The stock has been trending higher over the past 10 months with a trend channel forming.
For further details see:
Past Earnings And Revenue Growth Have Pushed Repligen Higher Ahead Of Q4 Earnings